Current Status of the Diagnosis and Management of Osteoporosis
Open accessThe DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Abstract
Osteoporosis has been defined as the silent disease of the 21st century, becoming a public health risk due to its severity, chronicity and progression and affecting mainly postmenopausal women and older adults. Osteoporosis is characterized by an imbalance between bone resorption and bone production. It is diagnosed through different methods such as bone densitometry and dual X-rays. The treatment of this pathology focuses on different aspects. On the one hand, pharmacological treatments are characterized by the use of anti-resorptive drugs, as well as emerging regenerative medicine treatments such as cell therapies and the use of bioactive hydrogels. On the other hand, non-pharmacological treatments are associated with lifestyle habits that should be incorporated, such as physical activity, diet and the cessation of harmful habits such as a high consumption of alcohol or smoking. This review seeks to provide an overview of the theoretical basis in relation to bone biology, the existing methods for diagnosis and the treatments of osteoporosis, including the development of new strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Thus, it is thought that imbalances in these molecular and cellular processes alter bone homeostasis, driving the pathophysiology of osteoporosis [5,6].”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“In addition to bone densitometry, general blood and urine tests can provide important information about an individual’s overall health and any underlying conditions that may be contributing to osteoporosis.”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“This classification is widely accepted as a diagnostic criterion, with sensitivity and specificity close to 90% [6].”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149 · cited 1×
“The primary purpose of a pharmacological treatment is to reduce the risk of fractures and to improve the quality of life of people with osteoporosis [90].”
BackgroundEuropean guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R., Reginster, J.-Y., & on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,948
Hernlund, E., Svedbom, A., Ivergård, M., Compston, J., Cooper, C., Stenmark, J., McCloskey, E. V., Jönsson, B., & Kanis, J. A. (2013) · Archives of Osteoporosis · doi:10.1007/s11657-013-0136-1 · Cited by 2,675 · cited 6×
“In 1993, the WHO defined osteoporosis as a systemic skeletal disease characterized by low bone mass, the deterioration of the microarchitecture of bone tissue, a consequent increase in bone fragility and a susceptibility to fractures [1].”
MethodInfluentialCompston, J. E., McClung, M. R., & Leslie, W. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32112-3 · Cited by 2,449
An overview and management of osteoporosis
Sözen, T., Özışık, L., & Çalık Başaran, N. (2019) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2016.048 · Cited by 2,262 · cited 3×
“Individuals with uncomplicated osteoporosis may remain asymptomatic until a fracture occurs [5].”
BackgroundDiagnosis of osteoporosis and assessment of fracture risk
Kanis, J. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08761-5 · Cited by 2,260 · cited 1×
“5–2; and (v) severe osteoporosis value: the risk is similar to that of established osteoporosis [89].”
BackgroundStroke risk factors, genetics, and prevention
Boehme, A. K., Esenwa, C., & Elkind, M. S. V. (2017) · Circulation Research · doi:10.1161/circresaha.116.308398 · Cited by 1,952 · cited 1×
“It is another clear cause of bone density loss, not only because of the drop in hormone levels but also because, histologically, there is a decrease in the average thickness of the bone wall, but bone resorption remains high with aging [34].”
BackgroundEuropean guidance for the diagnosis and management of osteoporosis in postmenopausal women
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J.-Y. (2019) · Osteoporosis International · doi:10.1007/s00198-018-4704-5 · Cited by 1,900 · cited 1×
“race, since Caucasians and Asians are at a greater risk than Blacks and Polynesians [32]; sex, since it has been found that the risk is greater in women than in men [33]; and age, since each decade increases the risk by 1.”
BackgroundHorwitz, E. M., Prockop, D. J., Fitzpatrick, L. A., Koo, W. W. K., Gordon, P. L., Neel, M., Sussman, M., Orchard, P., Marx, J. C., Pyeritz, R. E., et al. (1999) · Nature Medicine · doi:10.1038/6529 · Cited by 1,824 · cited 1×
“Decades ago, clinical studies were already conducted in children, using bone marrow MSCs (BM-MSCs) for the treatment of severe osteogenesis imperfecta [140].”
BackgroundGlobal vitamin D status and determinants of hypovitaminosis D
on behalf of the IOF Committee of Scientific Advisors (CSA) Nutrition Working Group, Mithal, A., Wahl, D. A., Bonjour, J.-P., Burckhardt, P., Dawson-Hughes, B., Eisman, J. A., El-Hajj Fuleihan, G., Josse, R. G., Lips, P., et al. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0954-6 · Cited by 1,472
Tang, B. M., Eslick, G. D., Nowson, C., Smith, C., & Bensoussan, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61342-7 · Cited by 1,248
Mechanisms of bone development and repair
Salhotra, A., Shah, H. N., Levi, B., & Longaker, M. T. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00279-w · Cited by 1,186 · cited 1×
“Osteocytes are the majority of bone cells capable of communicating directly with each other [39,40].”
BackgroundOsteoblast-Osteoclast Communication and Bone Homeostasis
Kim, J.-M., Lin, C., Stavre, Z., Greenblatt, M. B., & Shim, J.-H. (2020) · Cells · doi:10.3390/cells9092073 · Cited by 1,178 · cited 2×
“However, bone remodeling is also regulated by other systemic regulators (parathyroid hormone (PTH), vitamin D, calcitonin or glucocorticoids) and local regulators such as cytokines, growth factors mainly transforming growth factor beta (TGF-β), the macrophage colony-stimulating factor (M-CSF), receptor activators of n…”
BackgroundA Review of the Clinical Side Effects of Bone Morphogenetic Protein-2
James, A. W., LaChaud, G., Shen, J., Asatrian, G., Nguyen, V., Zhang, X., Ting, K., & Soo, C. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2015.0357 · Cited by 1,131 · cited 1×
“Recombinant human BMP-2 was, until a few years ago, the only osteoinductive growth factor approved by the FDA and the European Medicines Agency (EMA) for the treatment of long fractures [150].”
BackgroundBolland, M. J., Avenell, A., Baron, J. A., Grey, A., MacLennan, G. S., Gamble, G. D., & Reid, I. R. (2010) · BMJ · doi:10.1136/bmj.c3691 · Cited by 1,099 · cited 1×
“Nevertheless, at present, controversy has arisen over the consumption of calcium supplements since they are associated with cardiovascular disease [172,173] and, when they are not administered with vitamin D, with the risk of myocardial infarction [174].”
BackgroundLowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
Collaboration, H. L. T. (1998) · BMJ · doi:10.1136/bmj.316.7135.894 · Cited by 1,084 · cited 1×
“The consumption of folic acid and vitamin B-12 is expected to reduce the amount of homocysteine in the blood by a quarter or a third [190], which would slow down its degradative action on the extracellular matrix and decrease BMD [191].”
BackgroundExercise for preventing and treating osteoporosis in postmenopausal women
Howe, T. E., Shea, B., Dawson, L. J., Downie, F., Murray, A., Ross, C., Harbour, R. T., Caldwell, L. M., & Creed, G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000333.pub2 · Cited by 1,083
Osteoporosis treatment: recent developments and ongoing challenges
Khosla, S., & Hofbauer, L. C. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30188-2 · Cited by 1,019 · cited 1×
“Therefore, there is an increasing need for the development of new therapies that base their mechanisms on bone biology, have no side effects and promote bone formation and thereby a reduction in the risk of fractures [111].”
BackgroundSmoking and fracture risk: a meta-analysis
Kanis, J. A., Johnell, O., Oden, A., Johansson, H., De Laet, C., Eisman, J. A., Fujiwara, S., Kroger, H., McCloskey, E. V., Mellstrom, D., et al. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1640-3 · Cited by 999
Estrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860 · cited 1×
“Several hormones, primarily estrogens [59], are responsible for regulating bone remodeling by controlling the cytokines and growth factors produced by bone marrow and bone cells.”
BackgroundPremature menopause or early menopause: Long-term health consequences
Shuster, L. T., Rhodes, D. J., Gostout, B. S., Grossardt, B. R., & Rocca, W. A. (2010) · Maturitas · doi:10.1016/j.maturitas.2009.08.003 · Cited by 808 · cited 1×
“Endocrine factors include: (a) late menarche or menstrual cycle alterations, which are conditions that are associated with low bone mass [26]; (b) surgical or non-surgical menopause before the age of 45 years [27]; (c) being a hormonally infertile woman [28]; and (d) estrogen deficiency before menopause as a result of…”
BackgroundFragility fractures in Europe: burden, management and opportunities
for the International Osteoporosis Foundation, Borgström, F., Karlsson, L., Ortsäter, G., Norton, N., Halbout, P., Cooper, C., Lorentzon, M., McCloskey, E. V., Harvey, N. C., et al. (2020) · Archives of Osteoporosis · doi:10.1007/s11657-020-0706-y · Cited by 797 · cited 1×
“Moreover, in France, Sweden and Spain, 85%, 84% and 72% of fracture patients are without any treatment 1 year after fracture, respectively [120].”
BackgroundZhou, S., Greenberger, J. S., Epperly, M. W., Goff, J. P., Adler, C., LeBoff, M. S., & Glowacki, J. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00377.x · Cited by 785
Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis
Genant, H. K., Cooper, C., Poor, G., Reid, I., Ehrlich, G., Kanis, J., Nordin, B. E. C., Barrett-Connor, E., Black, D., Bonjour, J.-P., et al. (1999) · Osteoporosis International · doi:10.1007/s001980050224 · Cited by 783 · cited 1×
“In 1993, the WHO defined osteoporosis as a systemic skeletal disease characterized by low bone mass, the deterioration of the microarchitecture of bone tissue, a consequent increase in bone fragility and a susceptibility to fractures [1].”
BackgroundOxidative stress in bone remodeling: role of antioxidants
Domazetovic, V (2017) · Clinical Cases in Mineral and Bone Metabolism · doi:10.11138/ccmbm/2017.14.1.209 · Cited by 758
Osteoporosis: A Review of Treatment Options.
Tu, K. N., Lie, J. D., Wan, C. K. V., Cameron, M., Austel, A. G., Nguyen, J. K., Van, K., & Hyun, D. (2018) · PubMed · Cited by 735
Kenkre, J., & Bassett, J. (2018) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563218759371 · Cited by 693 · cited 16×
“RANKL/RANK binding induces a cascade of protein signaling molecules to enable osteoclast gene expression.”
BackgroundInfluentialKřížová, L., Dadáková, K., Kašparovská, J., & Kašparovský, T. (2019) · Molecules · doi:10.3390/molecules24061076 · Cited by 692
Effects of vitamin D supplements on bone mineral density: A systematic review and meta-analysis
Reid, I. R., Bolland, M. J., & Grey, A. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61647-5 · Cited by 678
Avenell, A., Gillespie, W. J., Gillespie, L. D., & O'Connell, D. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000227.pub3 · Cited by 667
Weaver, C. M., Alexander, D. D., Boushey, C. J., Dawson-Hughes, B., Lappe, J. M., LeBoff, M. S., Liu, S., Looker, A. C., Wallace, T. C., & Wang, D. D. (2016) · Osteoporosis International · doi:10.1007/s00198-015-3386-5 · Cited by 615 · cited 3×
“This vitamin promotes adequate blood calcium levels, which promote bone growth and remodeling from osteoblasts and osteoclasts, decreasing the risk of osteoporosis [91].”
BackgroundInfluentialThe cell biology of bone metabolism
Datta, H. K., Ng, W. F., Walker, J. A., Tuck, S. P., & Varanasi, S. S. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.048868 · Cited by 614 · cited 1×
“They are bone resorption cells and act by phagocytosing the matrix through acidification solubilization [41,42].”
BackgroundBiochemical markers of bone turnover: part I: biochemistry and variability.
Seibel, M. J. (2005) · Europe PMC (PubMed Central) · Cited by 584
Angiogenesis in bone regeneration
Hankenson, K. D., Dishowitz, M., Gray, C., & Schenker, M. (2011) · Injury · doi:10.1016/j.injury.2011.03.035 · Cited by 560 · cited 1×
“Smoking also induces inflammatory processes and increases oxidative stress, generating damage to the collagen metabolism, which acts as an important biochemical marker in bone metabolism in addition to inducing toxicity on bone cells by increasing the resistance to calcitonin, which blocks bone angiogenesis [223], pre…”
BackgroundBone mechanical properties and changes with osteoporosis
Osterhoff, G., Morgan, E. F., Shefelbine, S. J., Karim, L., McNamara, L. M., & Augat, P. (2016) · Injury · doi:10.1016/s0020-1383(16)47003-8 · Cited by 557 · cited 1×
“Likewise, hip fracture is considered to be the severe complication that is most associated with high morbidity and mortality [88].”
BackgroundBoskey, A. L., & Coleman, R. (2010) · Journal of Dental Research · doi:10.1177/0022034510377791 · Cited by 553 · cited 1×
“Over the years, bones become more fragile and lose their functionality [54].”
BackgroundThe role of DXA bone density scans in the diagnosis and treatment of osteoporosis
Blake, G. M., & Fogelman, I. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2007.057505 · Cited by 532 · cited 3×
“the diagnosis of osteoporosis is mainly based on the evaluation of bone mass by bone densitometry (DEXA) [67].”
BackgroundA meta-analysis of the effects of cigarette smoking on bone mineral density
Ward, K. D., & Klesges, R. C. (2001) · Calcified Tissue International · doi:10.1007/bf02390832 · Cited by 530
The roles of signaling pathways in bone repair and regeneration
Majidinia, M., Sadeghpour, A., & Yousefi, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26042 · Cited by 513 · cited 1×
“On the other hand, the main signaling pathways controlling osteoclastic bone resorption and osteoblastic bone formation are the receptor activators of nuclear factor-κB (RANK)/RANKL/osteoprotegerin (OPG) and the canonical Wnt signaling [65,66].”
BackgroundPrevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure
Lo, J. C., O'Ryan, F. S., Gordon, N. P., Yang, J., Hui, R. L., Martin, D., Hutchinson, M., Lathon, P. V., Sanchez, G., Silver, P., et al. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.03.050 · Cited by 493 · cited 1×
“However, the calcium intake in the general population remains below that recommended by different organizations (<700 mg/day) [126], mainly due to the limited supply of calcium-rich foods [169].”
BackgroundMandal, A., Clegg, J. R., Anselmo, A. C., & Mitragotri, S. (2020) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10158 · Cited by 491 · cited 1×
“Despite this, their clinical application is still scarce, and more studies are required to improve the aspects related to the use of polymeric biomaterials, their mechanical properties or their biodegradability [148].”
BackgroundHierarchical Structures of Bone and Bioinspired Bone Tissue Engineering
Liu, Y., Luo, D., & Wang, T. (2016) · Small · doi:10.1002/smll.201600626 · Cited by 482 · cited 1×
“In bone, there is a hierarchical structure with two separate phases: the organic matrix and the inorganic matrix [37].”
BackgroundQuantitative computed tomography
Adams, J. E. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.04.074 · Cited by 458 · cited 2×
“Nowadays. the diagnosis of osteoporosis is mainly based on the evaluation of bone mass by bone densitometry (DEXA) [67].”
BackgroundPrimary osteoporosis in postmenopausal women
Ji, M., & Yu, Q. (2015) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2015.02.006 · Cited by 436 · cited 1×
“During this stage, the estrogen deficit produces an increase in bone remodeling, which causes the loss of bone density [12].”
BackgroundHu, L., Yin, C., Zhao, F., Ali, A., Ma, J., & Qian, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020360 · Cited by 431 · cited 1×
“Physical and chemical factors also affect proper bone remodeling and formation and may be of help when it comes to treatment [144].”
BackgroundAtypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates
Black, D. M., Geiger, E. J., Eastell, R., Vittinghoff, E., Li, B. H., Ryan, D. S., Dell, R. M., & Adams, A. L. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916525 · Cited by 407 · cited 2×
“By 10 years, bisphosphonates treatment decreased the risk of osteoporotic and hip fractures and outweighed the increased risk of atypical fractures among White women (less so among Asian women) [129].”
BackgroundThe DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group (2010) · BMJ · doi:10.1136/bmj.b5463 · Cited by 398 · cited 1×
“However, some authors state that vitamin D supplementation alone has no effect on fracture risk [176,177] or BMD [178],”
BackgroundThe Prevalence of Autoimmune Disorders in Women: A Narrative Review
Angum, F., Khan, T., Kaler, J., Siddiqui, L., & Hussain, A. (2020) · Cureus · doi:10.7759/cureus.8094 · Cited by 397 · cited 1×
“5 million men and 22 million women in the European Union had osteoporosis according to the diagnostic criteria used by the WHO [13], with 80% of the female population being unaware of the risk factors before being diagnosed with the disease [14].”
MethodBone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease
Greenblatt, M. B., Tsai, J. N., & Wein, M. N. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.259085 · Cited by 376 · cited 2×
“β-CTX and NTX are considered to be the most useful resorption markers in clinical practice for the diagnosis of osteoporosis [78].”
BackgroundCalcium supplementation in clinical practice: a review of forms, doses, and indications
Straub, D. A. (2007) · Nutrition in Clinical Practice · doi:10.1177/0115426507022003286 · Cited by 374 · cited 1×
“Long periods of calcium deficiency lead to low BMD [170]; hence, the use of calcium supplementation has become very popular, with favorable effects in different populations and age groups [171].”
BackgroundOsteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011
Solomon, D. H., Johnston, S. S., Boytsov, N. N., McMorrow, D., Lane, J. M., & Krohn, K. D. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2202 · Cited by 368 · cited 1×
“The treatment gap is particularly marked in the case of hip fracture patients [121,122].”
BackgroundThe Regulation of Bone Metabolism and Disorders by Wnt Signaling
Maeda, K., Kobayashi, Y., Koide, M., Uehara, S., Okamoto, M., Ishihara, A., Kayama, T., Saito, M., & Marumo, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225525 · Cited by 353 · cited 2×
“On the other hand, the main signaling pathways controlling osteoclastic bone resorption and osteoblastic bone formation are the receptor activators of nuclear factor-κB (RANK)/RANKL/osteoprotegerin (OPG) and the canonical Wnt signaling [65,66].”
BackgroundGarrison, K., Donell, S., Ryder, J., Shemilt, I., Mugford, M., Harvey, I., & Song, F. (2007) · Health Technology Assessment · doi:10.3310/hta11300 · Cited by 341 · cited 1×
“However, the direct use of BMPs has been reported to lead to adverse effects, so the use of drug carriers is suggested as an option to reduce the doses applied and improve their cost-effectiveness [151].”
BackgroundDepartment of Oral Cell Biology, R. I. M., Klein-Nulend, J., Bacabac, R., & Bakker, A. (2012) · European Cells and Materials · doi:10.22203/ecm.v024a20 · Cited by 336
Association Between Alcohol Consumption and Both Osteoporotic Fracture and Bone Density
Berg, K. M., Kunins, H. V., Jackson, J. L., Nahvi, S., Chaudhry, A., Harris, K. A., Malik, R., & Arnsten, J. H. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.12.012 · Cited by 328 · cited 2×
“The protective effect of alcohol on bone health could be explained by its acute suppressive effect on bone resorption without the participation of PTH or calcitonin [212], as evidenced by the low levels of CTX associated with ethanol intake [213], while high alcohol consumption interferes with the calcium balance by d…”
BackgroundGuidelines for the management of osteoporosis and fragility fractures
Nuti, R., Brandi, M. L., Checchia, G., Di Munno, O., Dominguez, L., Falaschi, P., Fiore, C. E., Iolascon, G., Maggi, S., Michieli, R., et al. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1874-2 · Cited by 328 · cited 1×
“Moreover, the proximal ends of the femur and humerus, the distal end of the radius and the spine are the most susceptible to osteoporotic fractures in comparison to other parts of the bone [87].”
BackgroundThe clinical utility of bone marker measurements in osteoporosis
Wheater, G., Elshahaly, M., Tuck, S. P., Datta, H. K., & van Laar, J. M. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-201 · Cited by 322 · cited 1×
“carboxy-terminal ends in processes of bone matrix formation or degradation [79].”
BackgroundDietary protein and bone health: a systematic review and meta-analysis
Darling, A. L., Millward, D. J., Torgerson, D. J., Hewitt, C. E., & Lanham-New, S. A. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27799 · Cited by 310
Evaluation and Management of Vertebral Compression Fractures
Alexandru, D., & So, W. (2012) · The Permanente Journal · doi:10.7812/tpp/12-037 · Cited by 309 · cited 1×
“Although osteoporosis presents a general symptomatology, it also manifests with specific signs and symptoms such as: (i) pain that is secondary to osteoporotic fractures, which can occur in any bone and whose clinical manifestations depend on the location [15]; (ii) deformities and multiple vertebral compression fract…”
BackgroundWu, C.-H., Tu, S.-T., Chang, Y.-F., Chan, D.-C., Chien, J.-T., Lin, C.-H., Singh, S., Dasari, M., Chen, J.-F., & Tsai, K.-S. (2018) · Bone · doi:10.1016/j.bone.2018.03.018 · Cited by 307 · cited 1×
“Moreover, FLS provides an opportunity to improve the adherence to treatment, with a consequent reduction in the risk of refracture [131,132].”
BackgroundThe biology of normal bone remodelling
Katsimbri, P. (2017) · European Journal of Cancer Care · doi:10.1111/ecc.12740 · Cited by 306 · cited 1×
“They are bone resorption cells and act by phagocytosing the matrix through acidification solubilization [41,42].”
BackgroundLegume Natural Products: Understanding and Manipulating Complex Pathways for Human and Animal Health
Dixon, R. A., & Sumner, L. W. (2003) · Plant Physiology · doi:10.1104/pp.102.017319 · Cited by 293 · cited 1×
“Soy isoflavones are considered to be the most estrogenic compounds found mainly in the legumes of the Fabaceae family [184].”
BackgroundEffects of Resistance Exercise on Bone Health
Hong, A. R., & Kim, S. W. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.4.435 · Cited by 291 · cited 1×
“Environmental factors include: (a) nutritional factors, such as deficient calcium intake, vitamin D deficiency due to nutritional problems, poor absorption or low sun exposure, excessive protein intake in unbalanced diets, excessive phosphate intake or excessive salt intake that increases urinary calcium loss [22]; (b…”
BackgroundExpression of Estrogen Receptor β in Rat Bone
Onoe, Y., Miyaura, C., Ohta, H., Nozawa, S., & Suda, T. (1997) · Endocrinology · doi:10.1210/endo.138.10.5575 · Cited by 290
Molecular Mechanisms and Emerging Therapeutics for Osteoporosis
Noh, J.-Y., Yang, Y., & Jung, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207623 · Cited by 287 · cited 2×
“Osteoclasts, osteoblasts and osteocytes are bone cells directly involved in bone remodeling and a failure in their molecular mechanism is the possible trigger of the disease [57,58].”
BackgroundBiology of bone and how it orchestrates the form and function of the skeleton
D., S., & C., R. (2001) · European Spine Journal · doi:10.1007/s005860100283 · Cited by 283 · cited 1×
“The constant changes in bone mass and architecture due to load-bearing are regulated by osteoclasts together with the osteoblast–osteocyte communication system [48].”
BackgroundMesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy
Su, P., Tian, Y., Yang, C., Ma, X., Wang, X., Pei, J., & Qian, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082343 · Cited by 269 · cited 1×
“It would be interesting to monitor the injected cells and their ability to adhere to the damaged tissue to determine this [141].”
BackgroundAdvances in mesenchymal stem cell transplantation for the treatment of osteoporosis
Jiang, Y., Zhang, P., Zhang, X., Lv, L., & Zhou, Y. (2021) · Cell Proliferation · doi:10.1111/cpr.12956 · Cited by 265 · cited 1×
“Osteoporosis is a disease characterized by a change in cell differentiation, with osteogenic differentiation inhibited in favor of adipogenic differentiation [133].”
BackgroundNutrients and Dietary Patterns Related to Osteoporosis
Muñoz-Garach, A., García-Fontana, B., & Muñoz-Torres, M. (2020) · Nutrients · doi:10.3390/nu12071986 · Cited by 260 · cited 1×
“Environmental factors include: (a) nutritional factors, such as deficient calcium intake, vitamin D deficiency due to nutritional problems, poor absorption or low sun exposure, excessive protein intake in unbalanced diets, excessive phosphate intake or excessive salt intake that increases urinary calcium loss [22]; (b…”
BackgroundRegulation of Bone Remodeling by Parathyroid Hormone
Wein, M. N., & Kronenberg, H. M. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031237 · Cited by 241
Cell lines and primary cell cultures in the study of bone cell biology
Kartsogiannis, V., & Ng, K. W. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.06.002 · Cited by 236 · cited 1×
“Bone tissue is a dynamic, mineralized connective tissue that serves multiple physiological functions [36].”
BackgroundAnatomic connections of the diaphragm: influence of respiration on the body system
Bordoni, B., & Zanier (2013) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s45443 · Cited by 234 · cited 1×
“The last ribs could contact the iliac crest, causing the relaxation of the diaphragm, which is the cause of digestive (hiatus hernia, meteorism) and respiratory (dyspnea) manifestations [17].”
BackgroundMoreira, L. D. F., Oliveira, M. L. D., Lirani-Galvão, A. P., Marin-Mio, R. V., Santos, R. N. D., & Lazaretti-Castro, M. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003374 · Cited by 232 · cited 1×
“Some of the most commonly used training modalities in patients with osteoporosis are resistance exercise, aquatic exercise and proprioceptive training [204].”
MethodSingla, D., & Veqar, Z. (2017) · Journal of Chiropractic Medicine · doi:10.1016/j.jcm.2017.03.004 · Cited by 229 · cited 1×
“Moreover, increased dorsal kyphosis also occurs in osteoporotic males, resulting in shoulder droop, compensatory lumbar, cervical hyperlordosis and a characteristic postural habitus [20].”
BackgroundT-Cell Mediated Inflammation in Postmenopausal Osteoporosis
Wu, D., Cline-Smith, A., Shashkova, E., Perla, A., Katyal, A., & Aurora, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687551 · Cited by 227 · cited 2×
“while osteoblastic cells deteriorate, leading to a homeostatic imbalance of the bone [61].”
BackgroundCombating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity
Pagnotti, G. M., Styner, M., Uzer, G., Patel, V. S., Wright, L. E., Ness, K. K., Guise, T. A., Rubin, J., & Rubin, C. T. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0170-1 · Cited by 217 · cited 1×
“It is precisely these forces that promote osteogenesis and the cell differentiation of MSCs into an osteoblast lineage by dynamically activating the actin structure in the cytoskeleton while inhibiting adipogenesis [53].”
BackgroundEpidemiology and clinical features of osteoporosis in young individuals
Khosla, S., Lufkin, E. G., Hodgson, S. F., Fitzpatrick, L. A., & Melton, L. J. (1994) · Bone · doi:10.1016/8756-3282(94)90280-1 · Cited by 199 · cited 1×
“Secondary osteoporosis accounts for less than 5% of all cases of osteoporosis and is a consequence of a disease or the use of medications [7].”
BackgroundScreening and early diagnosis of osteoporosis through X-ray and ultrasound based techniques
Pisani, P. (2013) · World Journal of Radiology · doi:10.4329/wjr.v5.i11.398 · Cited by 193 · cited 2×
“Dual X-ray absorptiometry is based on the quantification of axial bone mineral density (spine and hip) by measuring the transmission of a beam of X-ray photons with two energy peaks in the patient’s body, which allows for the assessment of the calcium content of the bone [76].”
BackgroundLi, K., Wang, X.-F., Li, D.-Y., Chen, Y.-C., Zhao, L.-J., Liu, X.-G., Guo, Y.-F., Shen, J., Lin, X., Deng, J., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s157523 · Cited by 191 · cited 1×
“However, the calcium intake in the general population remains below that recommended by different organizations (<700 mg/day) [126], mainly due to the limited supply of calcium-rich foods [169].”
BackgroundIs there evidence for an age-related reduction in metabolic rate?
Piers, L. S., Soares, M. J., McCormack, L. M., & O’Dea, K. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.6.2196 · Cited by 189 · cited 6×
“Abbreviations MSCs: mesenchymal stem cells; BMD: bone mineral density; ALP: alkaline phosphatase; OPN: osteopontin; OC: osteocalcin; PTH: parathyroid hormone; TGF-β: transforming growth factor beta; M-CSF: macrophage colony-stimulating factor; RANKL: receptor activators of nuclear factor-κβ ligand; OPG: osteoprotegeri…”
BackgroundInfluentialHypothalamic Amenorrhea and the Long-Term Health Consequences
Torbati, T., Dutra, E., & Shufelt, C. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1603581 · Cited by 185 · cited 1×
“This is the most important risk factor for osteoporosis, at least in Western countries [29].”
BackgroundCollaboration, H. L. T. (1998) · PubMed Central · Cited by 181
Effects of exercise on fracture reduction in older adults: A systematic review and meta-analysis
Kemmler, W., Häberle, L., & von Stengel, S. (2013) · Osteoporosis International · doi:10.1007/s00198-012-2248-7 · Cited by 174 · cited 1×
“[203], through a systematic review with a meta-analysis, concludes that, although positive effects of exercise on fracture risk in old age were found, they were weak.”
BackgroundCarvalho, M. S., Cabral, J. M. S., da Silva, C. L., & Vashishth, D. (2021) · Polymers · doi:10.3390/polym13071095 · Cited by 174 · cited 1×
“In situations of increased bone turnover, the half-life of OC decreases, and it is eliminated through urine [82].”
BackgroundThe Effect of Exercise on the Prevention of Osteoporosis and Bone Angiogenesis
Tong, X., Chen, X., Zhang, S., Huang, M., Shen, X., Xu, J., & Zou, J. (2019) · BioMed Research International · doi:10.1155/2019/8171897 · Cited by 171 · cited 2×
“BMD depends on the dynamic balance between bone formation and resorption [195], with mechanical loads being the main stimulus for osteoblastic differentiation and mineralization, promoting adequate bone mass and density [196].”
BackgroundSide effects of drugs for osteoporosis and metastatic bone disease
Skjødt, M. K., Frost, M., & Abrahamsen, B. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13759 · Cited by 171 · cited 1×
“Therefore, it is essential to know the factors involved in this disease and to establish approaches for its management and treatment [35].”
BackgroundRisk factors for osteoporosis and associated fractures.
Kelsey, J. L. (1989) · Public Health Reports · Cited by 169
Denosumab: A review in postmenopausal osteoporosis
Deeks, E. D. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0525-7 · Cited by 169 · cited 1×
“Denosumab is more effective at improving bone density and strength than bisphosphonate drugs, but unlike bisphosphonate drugs, it is not incorporated into bone, so its effect ceases when the treatment is stopped [103].”
BackgroundAdverse Effects of Bisphosphonates
Abrahamsen, B. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9364-1 · Cited by 165 · cited 1×
“In the most severe cases, reactions in the upper gastrointestinal tract may also include esophageal erosion or esophageal ulcers [124].”
BackgroundAvenell, A., Gillespie, W. J., Gillespie, L. D., & O'Connell, D. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000227.pub2 · Cited by 165
Marx, R. E. (2007) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/j.coms.2007.07.008 · Cited by 160 · cited 1×
“Bone is unique in the healing of connective tissue because it is capable of complete healing through cell regeneration and mineral matrix production [47].”
BackgroundMechanisms by which exercise improves bone strength
Turner, C. H., & Robling, A. G. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/bf03026318 · Cited by 159 · cited 1×
“On the one hand, resistance exercise seems to act on the bone from the myotendinous junction, where the increase in tendon tension resulting from muscle contraction stimulates the osteogenic response of the bone, increasing BMD [205].”
BackgroundOsteoporosis prevention and nutrition
Tucker, K. L. (2009) · Current Osteoporosis Reports · doi:10.1007/s11914-009-0020-5 · Cited by 151
Stanghelle, B., Bentzen, H., Giangregorio, L., Pripp, A. H., Skelton, D. A., & Bergland, A. (2020) · Osteoporosis International · doi:10.1007/s00198-019-05256-4 · Cited by 148 · cited 1×
“Finally, proprioceptive exercises are also one of the main strategies to address the osteoporotic population; the improvement in the perception of the location of their own body in space from exercise has been shown to decrease the risk of falls and increase mobility, in addition to improving functional capacity and d…”
BackgroundBone Development: Overview of Bone Cells and Signaling
Teti, A. M. (2011) · Current Osteoporosis Reports · doi:10.1007/s11914-011-0078-8 · Cited by 147 · cited 2×
“This process is based on the balance of two main phases: bone formation and bone resorption (Figure 1) [46].”
BackgroundThe Effect of Exercise on Bone Mass and Structural Geometry during Growth
Daly, R. M. (2007) · KARGER eBooks · doi:10.1159/000103003 · Cited by 144 · cited 1×
“Disuse can lead to deterioration in bone density and architecture, but physical exercise can slow the progression of these problems [52].”
BackgroundDiagnostic tests: Bone mineral density: Testing for osteoporosis
Sheu, A., & Diamond, T. (2016) · Australian Prescriber · doi:10.18773/austprescr.2016.020 · Cited by 138 · cited 1×
“There are also several diagnostic tests used to monitor the treatment of osteoporosis in clinical practice [74], including dual X-ray absorptiometry, which is the most recommended technique for the diagnosis of osteoporosis since it can predict the risk of fracture, indicate the treatment or monitor its effect [75].”
Calcium Supplements and Fracture Prevention
Bauer, D. C. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1210380 · Cited by 137
Osteoporosis: the current status of mesenchymal stem cell-based therapy
Phetfong, J., Sanvoranart, T., Nartprayut, K., Nimsanor, N., Seenprachawong, K., Prachayasittikul, V., & Supokawej, A. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0013-1 · Cited by 136
Stem Cell Therapy for Osteoporosis
Antebi, B., Pelled, G., & Gazit, D. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-013-0184-x · Cited by 133 · cited 1×
“The cells themselves do not recognize the bone surfaces to be treated, which can trigger cell differentiation to another, non-osteogenic type, and this type of graft is not able to be maintained in the long term [145].”
BackgroundKado, D. M., Huang, M.-H., Karlamangla, A. S., Cawthon, P. M., Katzman, W. B., Hillier, T. A., Ensrud, K. E., & Cummings, S. R. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1728 · Cited by 131 · cited 1×
“Likewise, hyperkyphosis causes cervical pain as the patient tries to keep the head upright through cervical hyperextension [19].”
BackgroundBuck, D. W., & Dumanian, G. A. (2012) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e31824eca94 · Cited by 128
Osteopontin regulates type I collagen fibril formation in bone tissue
Dépalle, B., McGilvery, C. M., Nobakhti, S., Aldegaither, N., Shefelbine, S. J., & Porter, A. E. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.04.040 · Cited by 120 · cited 1×
“It acts as a link at the mineral–collagen interface, improving bone hardness [50].”
BackgroundUse of Osteoporosis Medications after Hospitalization for Hip Fracture: A Cross-national Study
Kim, S. C., Kim, M., Sanfélix‐Gimeno, G., Song, H. J., Liu, J., Hurtado, I., Peiró, S., Lee, J., Choi, N., Park, B., et al. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.01.014 · Cited by 119 · cited 2×
“Moreover, the adherence to osteoporosis treatment was also suboptimal [122].”
BackgroundEthnic Differences in Bone Health
Zengin, A., Prentice, A., & Ward, K. A. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00024 · Cited by 116
The Development of Molecular Biology of Osteoporosis
Gao, Y., Patil, S., & Jia, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158182 · Cited by 116 · cited 1×
“However, bone remodeling is also regulated by other systemic regulators (parathyroid hormone (PTH), vitamin D, calcitonin or glucocorticoids) and local regulators such as cytokines, growth factors mainly transforming growth factor beta (TGF-β), the macrophage colony-stimulating factor (M-CSF), receptor activators of n…”
BackgroundEverts‐Graber, J., Lehmann, D., Burkhard, J.-P., Schaller, B., Gahl, B., Häuselmann, H., Studer, U., Ziswiler, H., Reichenbach, S., & Lehmann, T. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4472 · Cited by 116 · cited 1×
“Of these 17 patients, 12 were receiving denosumab at the time of ONJ diagnosis, and 5 of the patients were treated with oral or intravenous bisphosphonate therapy [127].”
BackgroundQuattrocchi, E. J., & Kourlas, H. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90128-2 · Cited by 115 · cited 1×
“Teriparatide promotes osteoblastogenesis and prevents osteoblastic apoptosis [104,105].”
BackgroundGrabowski, P. (2009) · Endocrine development · doi:10.1159/000223687 · Cited by 114
Prospect of mesenchymal stem cells in therapy of osteoporosis: A review
Maleki, L. A., Dolati, S., Zandi, R., Fotouhi, A., Ahmadi, M., Aghebati, A., Nouri, M., Shakouri, S. K., & Yousefi, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27833 · Cited by 112 · cited 1×
“However, embryonic stem cells or induced pluripotent stem cells have been discarded due to ethical and safety concerns [137].”
BackgroundPrimary osteoporosis in postmenopausal women
Ji, M., & Yu, Q. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.06.009 · Cited by 111
The Treatment Gap in Osteoporosis
Ayub, N., Faraj, M., Ghatan, S., Reijers, J. A. A., Napoli, N., & Oei, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10133002 · Cited by 110 · cited 1×
“Hence, there is the so-called “treatment gap” in bone fragility management, which leads to an increase in the burden of osteoporotic fracture for individuals, societies and healthcare systems [113].”
BackgroundNutrition and Bone Health in Women after the Menopause
Rizzoli, R., Bischoff-Ferrari, H. A., Dawson-Hughes, B. F., & Weaver, C. M. (2014) · Women s Health · doi:10.2217/whe.14.40 · Cited by 107
Zhu, K., & Prince, R. L. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0248-6 · Cited by 106
Díez‐Pérez, A., Hooven, F. H., Adachi, J. D., Adami, S., Anderson, F. A., Boonen, S., Chapurlat, R. D., Compston, J. E., Cooper, C. C., Delmas, P. D., et al. (2011) · Bone · doi:10.1016/j.bone.2011.05.007 · Cited by 104 · cited 1×
“Many studies pointed out that a minority of individuals at a high fracture risk actually receive treatment [116,117].”
BackgroundEpidemiología de la osteoporosis
Naranjo, L. A. G., Vásquez, G. M., & Molina, J. F. (2009) · Revista Colombiana de Reumatología · doi:10.1016/s0121-8123(09)70119-7 · Cited by 103
Risk factors for osteoporosis and associated fractures.
Kelsey, J. L. (1989) · Europe PMC (PubMed Central) · Cited by 99
Prospect of Stem Cell Therapy and Regenerative Medicine in Osteoporosis
Arjmand, B., Sarvari, M., Alavi-Moghadam, S., Payab, M., Goodarzi, P., Gilany, K., Mehrdad, N., & Larijani, B. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00430 · Cited by 99 · cited 1×
“The results showed that, by using a high number of progenitor stem cells with good proliferation and differentiation capacities, it is possible to control bone resorption, decrease fracture damage and improve tissue mineral density in the treatment of osteoporosis [138].”
BackgroundSingh, S., Dutta, S., Khasbage, S. U., Kumar, T., Sachin, J., Sharma, J., & Varthya, S. B. (2021) · Osteoporosis International · doi:10.1007/s00198-021-06095-y · Cited by 98 · cited 1×
“However, these novel osteoporosis therapies are still under study [109,110], and the current ones are not fully effective in all patients and also present serious side effects which limit their long-term use.”
BackgroundMarin, R. V., Pedrosa, M. A. C., Moreira, L. D. F., Matsudo, S. M., & Lazaretti‐Castro, M. (2010) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2009.12.001 · Cited by 97 · cited 1×
“The usual practice of physical exercise has an important effect on body weight, which is closely related to BMD, the most important component of body composition, and lean mass for its effects on BMD in the whole body, while fat mass has only been related to femoral neck BMD [200].”
BackgroundAlendronate: An Update of its Use in Osteoporosis
Sharpe, M., Noble, S., & Spencer, C. M. (2001) · Drugs · doi:10.2165/00003495-200161070-00010 · Cited by 97
Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis
Dhillon, S. (2016) · Drugs · doi:10.1007/s40265-016-0662-4 · Cited by 96
Direct transcriptional targets of sex steroid hormones in bone
Krum, S. A. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22970 · Cited by 94 · cited 1×
“The constant practice of physical exercise promotes the proliferation of estrogens [197], which are bone protectors since they slow down the production of osteoclastic cytokines, favor the proliferation of osteoblasts and decrease osteocyte apoptosis [198].”
BackgroundCaeiro, J. R., González, P., & Guede, D. (2013) · Revista de Osteoporosis y Metabolismo Mineral · doi:10.4321/s1889-836x2013000200007 · Cited by 94 · cited 1×
“This matrix is responsible for the stiffness of the bone and its resistance to compressive forces in a way that depends on the amount of mineral, the arrangement of the crystals and the degree of packing [38].”
BackgroundUreña, P., Ferreira, A., Kung, V. T., Morieux, C., Simon, P., Ang, K. S., Souberbielle, J., Segre, G. V., Drüeke, T. B., & de Vernejoul, M. C. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100614 · Cited by 93 · cited 1×
“On the other hand, the most commonly used resorption markers that measure osteoclast activity are: (i) Pyridinolines (Pir) and deoxypyridinoline (Dpir), which link collagen molecules in the bone matrix through covalent bonds, thus forming fibrils [83]; and (ii) ICTP (C-terminal telopeptide of type I collagen), β-CTX (…”
BackgroundDang, M., Koh, A. J., Jin, X., McCauley, L. K., & Ma, P. X. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.049 · Cited by 93 · cited 1×
“PTH anabolic treatments were the first Food and Drug Administration (FDA)-approved osteoporosis medications that could stimulate new bone formation [64].”
BackgroundClinical Use of Bone Densitometry
Bates, D. W., Black, D. M., & Cummings, S. R. (2002) · JAMA · doi:10.1001/jama.288.15.1898 · Cited by 91 · cited 1×
“However, limitations exist in this imaging test, especially in the presence of osteomalacia, osteoarthrosis and osteoarthritis [72].”
BackgroundA review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures
Abrahamsen, B., Brask-Lindemann, D., Rubin, K. H., & Schwarz, P. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2014.69 · Cited by 90 · cited 1×
“Environmental factors include: (a) nutritional factors, such as deficient calcium intake, vitamin D deficiency due to nutritional problems, poor absorption or low sun exposure, excessive protein intake in unbalanced diets, excessive phosphate intake or excessive salt intake that increases urinary calcium loss [22]; (b…”
BackgroundLappin, D. F., Sherrabeh, S., Jenkins, W. M. M., & Macpherson, L. M. D. (2007) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2007.01048.x · Cited by 90 · cited 1×
“Tang and Lappin, in their articles, studied this phenomenon, finding that individuals who smoked cigarettes presented a lower level of OPG, while the RANKL (receptor activator of nuclear factor κβ ligand), which works as a stimulant of osteoclastic maturation and activity, was higher than those found in nonsmoking sub…”
BackgroundLu, M.-P., Wang, R., Song, X., Chibbar, R., Wang, X., Wu, L., & Meng, Q. H. (2008) · Nutrition Research · doi:10.1016/j.nutres.2008.03.009 · Cited by 88 · cited 1×
“These bioactive compounds have been deeply studied in recent years; it has been found that they have favorable effects on glucose levels [185], breast cancer risk [186] and osteoporosis [187], among others.”
BackgroundDiagnosis and management of osteoporosis in the older senior
Vondracek, S. F., & Linnebur, S. A. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s4965 · Cited by 87 · cited 1×
“Although osteoporosis presents a general symptomatology, it also manifests with specific signs and symptoms such as: (i) pain that is secondary to osteoporotic fractures, which can occur in any bone and whose clinical manifestations depend on the location [15]; (ii) deformities and multiple vertebral compression fract…”
BackgroundMultiscale modeling of bone tissue mechanobiology
García‐Aznar, J. M., Nasello, G., Hervás-Raluy, S., Pérez, M. Á., & Gómez‐Benito, M. J. (2021) · Bone · doi:10.1016/j.bone.2021.116032 · Cited by 87 · cited 1×
“Bone remodeling begins in fetal life and continues throughout our lives, adapting the shape of bones by removing and adding bone tissue at different key points [45].”
BackgroundMelatonin Effects on Hard Tissues: Bone and Tooth
Liu, J., Huang, F. P., & He, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140510063 · Cited by 86 · cited 1×
“Melatonin is a hormone that has previously demonstrated its capacity for cell differentiation and bone remodeling and its usefulness in curbing excessive oxidative stress [159].”
BackgroundZhao, Y., Li, Z., Jiang, Y., Liu, H., Feng, Y., Wang, Z., Liu, H., Wang, J., Yang, B., & Lin, Q. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.06.024 · Cited by 86 · cited 3×
“Some of these markers are indicators of osteobl stic activity and the resulting metabol sm after coll gen rele se [49].”
BackgroundInfluentialOsteoporosis Prevention and Management: Nonpharmacologic and Lifestyle options
Christianson, M. S., & Shen, W. (2013) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e3182a9d15a · Cited by 83 · cited 4×
“Theoretically, folic acid and vitamin B-12 could have important effects on fracture risk due to their action on homocysteine metabolism [170].”
BackgroundInfluentialCalcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
Sui, B., Hu, C., Zhang, X., Zhao, P., He, T., Zhou, C., Qiu, X., Chen, N., Zhao, X., & Jin, Y. J. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0347 · Cited by 83 · cited 1×
“The transplantation of allogeneic BMMSCs reduced the loss of bone tissue mass and hardness and promoted osteoblastogenesis while maintaining bone formation [143].”
BackgroundYuan, S., Michaëlsson, K., Wan, Z., & Larsson, S. C. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00606-0 · Cited by 83 · cited 1×
“Smoking also induces inflammatory processes and increases oxidative stress, generating damage to the collagen metabolism, which acts as an important biochemical marker in bone metabolism in addition to inducing toxicity on bone cells by increasing the resistance to calcitonin, which blocks bone angiogenesis [223], pre…”
BackgroundOsteoporosis and the Potential of Cell-Based Therapeutic Strategies
Macías, I., Alcorta-Sevillano, N., Rodríguez, C. I., & Infante, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051653 · Cited by 82 · cited 1×
“This type of therapy focuses on the ability of cells to repair damaged tissue [135].”
BackgroundLife-course approach to nutrition
Mitchell, P., Cooper, C. C., Dawson-Hughes, B. F., Gordon, C. M., & Rizzoli, R. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3288-6 · Cited by 81 · cited 1×
“Protein intake is an important nutritional factor for bone health, as it provides the amino acids necessary for the construction of the bone matrix and stimulates bone formation from IGF-I [180].”
BackgroundNew insights into the epigenetics of osteoporosis
Letarouilly, J.-G., Broux, O., & Clabaut, A. (2018) · Genomics · doi:10.1016/j.ygeno.2018.05.001 · Cited by 81 · cited 1×
“In addition, osteoporosis has been reported to occur when there is an imbalance in bone cell function [2].”
BackgroundNovel therapies for osteoporosis
Makras, P., Delaroudis, S., & Anastasilakis, A. D. (2015) · Metabolism · doi:10.1016/j.metabol.2015.07.011 · Cited by 80
Gillespie, W., Avenell, A., Henry, D. A., O'Connell, D., & Robertson, J. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000227 · Cited by 77 · cited 1×
“However, some authors state that vitamin D supplementation alone has no effect on fracture risk [176,177] or BMD [178],”
BackgroundJugdaohsingh, R., O'Connell, M. A., Sripanyakorn, S., & Powell, J. J. (2006) · Proceedings of The Nutrition Society · doi:10.1079/pns2006508 · Cited by 76 · cited 1×
“The protective effect of alcohol on bone health could be explained by its acute suppressive effect on bone resorption without the participation of PTH or calcitonin [212], as evidenced by the low levels of CTX associated with ethanol intake [213], while high alcohol consumption interferes with the calcium balance by d…”
BackgroundBone microarchitecture and strength
Dempster, D. W. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1474-4 · Cited by 74 · cited 1×
“Both types of bone are similar in their cellular and molecular composition but different in terms of functionality and mechanical characteristics [43].”
BackgroundOsteoporosis in 2022: Care gaps to screening and personalised medicine
Curtis, E. M., Dennison, E. M., Cooper, C. C., & Harvey, N. C. (2022) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2022.101754 · Cited by 74 · cited 1×
“However, it has been shown that the proportion of patients starting treatment to reduce the risk of future fracture within the year following a diagnosis of fracture is low [119].”
BackgroundRisedronate: A Review of its Pharmacological Properties and Clinical Use in Resorptive Bone Disease
Dunn, C. J., & Goa, K. L. (2001) · Drugs · doi:10.2165/00003495-200161050-00013 · Cited by 72
Nafee, N. A., Zewail, M., & Boraie, N. A. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1390670 · Cited by 72 · cited 1×
“In addition, alendronate-loaded hydrogel was shown to have a lower inflammatory response, higher cell proliferation and faster tissue maturation [162].”
BackgroundLi, D., Zhou, J. F., Zhang, M., Ma, Y., Yang, Y., Han, X., & Wang, X. (2020) · Biomaterials Science · doi:10.1039/d0bm00376j · Cited by 72 · cited 1×
“These hydrogels effectively promoted bone regeneration at the implantation site in a minimally invasive manner [156].”
BackgroundThe Osteoporosis/Microbiota Linkage: The Role of miRNA
Martinis, M. D., Ginaldi, L., Allegra, A., Sirufo, M. M., Pioggia, G., Tonacci, A., & Gangemi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238887 · Cited by 71 · cited 1×
“The consumption of folic acid and vitamin B-12 is expected to reduce the amount of homocysteine in the blood by a quarter or a third [190], which would slow down its degradative action on the extracellular matrix and decrease BMD [191].”
BackgroundBazedoxifene for the treatment of osteoporosis
Yavropoulou, M. P., Makras, P., & Anastasilakis, A. D. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1615882 · Cited by 69 · cited 1×
“Bazedoxifene, binds at the cellular level to both ERα and Erβ and inhibits its binding to 17β-estradiol, exerting agonistic activity on the bone [97].”
BackgroundParker, S. E., Troisi, R. J., Wise, L. A., Palmer, J. R., Titus-Ernstoff, L. T., Strohsnitter, W. C., & Hatch, E. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2954 · Cited by 68 · cited 1×
“Endocrine factors include: (a) late menarche or menstrual cycle alterations, which are conditions that are associated with low bone mass [26]; (b) surgical or non-surgical menopause before the age of 45 years [27]; (c) being a hormonally infertile woman [28]; and (d) estrogen deficiency before menopause as a result of…”
BackgroundCui, Z., Feng, H., He, B., He, J., & Tian, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.763538 · Cited by 68
An Overlooked Bone Metabolic Disorder: Cigarette Smoking-Induced Osteoporosis
Weng, W., Li, H., & Zhu, S. (2022) · Genes · doi:10.3390/genes13050806 · Cited by 65
Kaur, R., & Makula, A. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.104956 · Cited by 65 · cited 1×
“bone in the trabecular region of osteoporotic rat femurs and an increase in load-bearing with respect to the damaged tissue [161].”
BackgroundEfficacy and safety of currently marketed anti-osteoporosis medications
Reginster, J., Neuprez, A., Dardenne, N., Beaudart, C., Emonts, P., & Bruyère, O. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.09.003 · Cited by 63 · cited 2×
“However, it has been suggested that the prolonged use of PTH analogs increases the risk of osteosclerosis and osteosarcoma due to their stimulatory effects, and they are not used for the long-term treatment of osteoporosis [93].”
BackgroundReference Ranges for Bone Mineral Density and Prevalence of Osteoporosis in Vietnamese Men and Women
Ho-Pham, L. T., T Nguyen, U. D., Pham, H. N., Nguyen, N. D., & Nguyen, T. V. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-182 · Cited by 63 · cited 1×
“The T-score or t-value, which is the number of standard deviations above or below the mean BMD of the normal young population of the same sex, has been taken into account for this classification [70].”
BackgroundSwimming as Treatment for Osteoporosis: A Systematic Review and Meta‐analysis
Su, Y., Chen, Z., & Xie, W. (2020) · BioMed Research International · doi:10.1155/2020/6210201 · Cited by 63 · cited 1×
“Previously, it was believed that aquatic exercises decreased BMD; however, studies such as that by Su, Chen and Xie [207] show the opposite.”
BackgroundCrandall, C. J., Larson, J. C., LaCroix, A. Z., Cauley, J. A., LeBoff, M. S., Li, W., LeBlanc, E. S., Edwards, B. J.-A., Manson, J. E., & Ensrud, K. E. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4696-z · Cited by 60 · cited 1×
“For example, the FRAX and Garvan risk calculators have demonstrated a low ability to identify the risk of hip fractures, major osteoporotic fractures or any clinical fractures in postmenopausal women aged 50–64 years during 10 years of follow-up [115].”
BackgroundBone and Soft-Tissue Biopsies: What You Need to Know
Charalampopoulos, G., Mazioti, A., Keramida, K., Kelekis, A., & Filippiadis, D. K. (2018) · Seminars in Interventional Radiology · doi:10.1055/s-0038-1669467 · Cited by 59 · cited 1×
“This is a very invasive technique in which a tissue sample is extracted, and it is only performed when evidence of tumors is detected [85].”
MethodLeder, B. Z., Mitlak, B., Hu, M., Hattersley, G., & Bockman, R. S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz162 · Cited by 59 · cited 1×
“Some studies have shown that the use of Abaloparatide reduces the risk of vertebral fractures in postmenopausal women with osteoporosis compared to patients treated using alendronate [106].”
BackgroundWeaver, C. M. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0208-1 · Cited by 58 · cited 1×
“Nevertheless, at present, controversy has arisen over the consumption of calcium supplements since they are associated with cardiovascular disease [172,173] and, when they are not administered with vitamin D, with the risk of myocardial infarction [174].”
BackgroundAsadipooya, K., & Weinstock, A. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312371 · Cited by 58 · cited 1×
“The treatment with this anti-sclerostin antibody might increase cardiovascular damage and therefore the risk of cardiovascular complications such as cardiac ischemic or cerebrovascular events [130].”
BackgroundSegredo-Morales, E., García‐García, P., Reyes, R., Pérez‐Herrero, E., Delgado, A., & Évora, C. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.03.034 · Cited by 56 · cited 1×
“However, the mineralization of newly formed bone in the osteoporosis groups was markedly lower than that in the non-osteoporosis groups [154].”
BackgroundNovel therapies in osteoporosis: PTH-related peptide analogs and inhibitors of sclerostin
Rachner, T. D., Hofbauer, L. C., Göbel, A., & Tsourdi, E. A. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0173 · Cited by 56
Xiao, L., Lin, J., Chen, R., Huang, Y., Liu, Y., Bai, J., Ge, G., Shi, X., Chen, Y., Shi, J., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6797154 · Cited by 56 · cited 1×
“In addition, it increased the bone mass around the implant in ovariectomized rats treated with this adhesive [160].”
BackgroundTeriparatide in the treatment of osteoporosis
Stroup, J. S., Kane, M. P., & Abu-Baker, A. M. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070171 · Cited by 55 · cited 1×
“Teriparatide promotes osteoblastogenesis and prevents osteoblastic apoptosis [104,105].”
BackgroundEchave, M. C., Erezuma, I., Golafshan, N., Castilho, M. D., Kadumudi, F. B., Pimenta-Lopes, C., Ventura, F., Pujol, A., Jimenez, J. J., Cámara, J. A., et al. (2021) · Biomaterials Advances · doi:10.1016/j.msec.2021.112539 · Cited by 55 · cited 1×
“In this study, it was demonstrated that the hydrogels promoted the adhesion and proliferation of human bone marrow-derived MSCs and also promoted the osteogenic differentiation of the cells [152].”
BackgroundTang, T. H., Fitzsimmons, T. R., & Bartold, P. M. (2009) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2009.01444.x · Cited by 52 · cited 1×
“Tang and Lappin, in their articles, studied this phenomenon, finding that individuals who smoked cigarettes presented a lower level of OPG, while the RANKL (receptor activator of nuclear factor κβ ligand), which works as a stimulant of osteoclastic maturation and activity, was higher than those found in nonsmoking sub…”
BackgroundSkeletal System Biology and Smoke Damage: From Basic Science to Medical Clinic
Tarantino, U., Cariati, I., Greggi, C., Gasbarra, E., Belluati, A., Ciolli, L., Maccauro, G., Momoli, A., Ripanti, S., Falez, F., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126629 · Cited by 52 · cited 2×
“However, it is unclear which of the toxins found in cigarettes are specifically related to the alteration of bone health [219].”
BackgroundSirufo, M. M., Pietro, F. D., Bassino, E. M., Ginaldi, L., & Martinis, M. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134749 · Cited by 52 · cited 1×
“Moreover, there are alterations of the adipose panniculus and the presence of skin folds on the back, pubic region and umbilicus [18].”
BackgroundBramati, A., Girelli, S., Farina, G., Dazzani, M. C., Torri, V., Moretti, A., Piva, S., Dimaiuta, M., & Verde, N. M. L. (2014) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-014-0566-x · Cited by 50 · cited 1×
“Interestingly, it has been highlighted that dental management by the screening and treatment of oral diseases during and also after the treatment with ONJ-related drugs can significantly reduce the occurrence of this disease [128].”
BackgroundSripanyakorn, S., Jugdaohsingh, R., Mander, A., Davidson, S. L., Thompson, R. P. H., & Powell, J. J. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090222 · Cited by 50 · cited 1×
“The protective effect of alcohol on bone health could be explained by its acute suppressive effect on bone resorption without the participation of PTH or calcitonin [212], as evidenced by the low levels of CTX associated with ethanol intake [213], while high alcohol consumption interferes with the calcium balance by d…”
BackgroundCalcium metabolism and vitamin D in the extreme longevity
Passeri, G., Vescovini, R., Sansoni, P., Galli, C., Franceschi, C., & Passeri, M. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.06.013 · Cited by 49 · cited 1×
“This leads to a negative calcium balance and, consequently, to the deterioration of bone tissue [62].”
BackgroundThe effects of smoking on estradiol metabolism.
Tansavatdi, K., McClain, B. P., & Herrington, D. M. (2004) · PubMed · Cited by 46
Injectable Hydrogels as Three-Dimensional Network Reservoirs for Osteoporosis Treatment
Zheng, Z., Yu, C., & Wei, H. (2020) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2020.0168 · Cited by 46 · cited 1×
“This makes it possible to control the degradation rate of the hydrogel, generating an excellent vehicle for the controlled release of drugs [149].”
BackgroundBentz, A. T., Schneider, C. M., & Westerlind, K. C. (2005) · Cancer Causes & Control · doi:10.1007/s10552-004-6256-6 · Cited by 42
Papathanasiou, K. E., Turhanen, P. A., Brückner, S. I., Brunner, E., & Demadis, K. D. (2017) · Scientific Reports · doi:10.1038/s41598-017-04956-3 · Cited by 42
Bone Toolbox: Biomarkers, Imaging Tools, Biomechanics, and Histomorphometry
Varela, A., & Jolette, J. (2018) · Toxicologic Pathology · doi:10.1177/0192623318779565 · Cited by 42 · cited 1×
“Collagen type I is a protein synthesized by the osteoblasts and also serves as a bone formation marker [51].”
BackgroundHydrogels in Tissue Engineering: Scope and Applications
Vashist, A., & Ahmad, S. (2015) · Current Pharmaceutical Biotechnology · doi:10.2174/138920101607150427111651 · Cited by 41 · cited 1×
“They act as a substitute for the conventional materials used in restorative surgery by combining biology and engineering, improving and restoring tissue function [147].”
BackgroundLu, C.-H., Chen, Y., Ke, C., & Liu, R.-S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312750 · Cited by 41 · cited 1×
“This would facilitate its application in the clinic [142].”
BackgroundMcLernon, D. J., Powell, J. J., Jugdaohsingh, R., & Macdonald, H. M. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.021600 · Cited by 40 · cited 1×
“On the other hand, lifestyle habits do not seem to be related to the protective effect of moderate alcohol consumption in women close to menopause [211].”
BackgroundRole of Hydrogels in Bone Tissue Engineering: How Properties Shape Regeneration
Wu, Y., Zhang, X., Zhao, Q., Tan, B., Chen, X., & Liao, J. (2020) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2020.2997 · Cited by 40 · cited 1×
“These properties directly influence the cell migration, proliferation and differentiation of MSCs, which favors bone regeneration [146].”
BackgroundBone mechanobiology, gravity and tissue engineering: effects and insights
Ruggiu, A., & Cancedda, R. (2014) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1942 · Cited by 38 · cited 1×
“Factors such as immobilization, hormonal or nutritional deficiencies or chronic diseases can metabolically affect bone remodeling leading to osteopenia [55].”
BackgroundGuggina, P., Flahive, J., Hooven, F. H., Watts, N. B., Siris, E. S., Silverman, S. L., Roux, C., Pfeilschifter, J., Greenspan, S. L., Díez‐Pérez, A., et al. (2012) · Bone · doi:10.1016/j.bone.2012.08.130 · Cited by 38 · cited 1×
“Many studies pointed out that a minority of individuals at a high fracture risk actually receive treatment [116,117].”
BackgroundAshrafi, M., Ghalichi, F., Mirzakouchaki, B., & Doblaré, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-82502-y · Cited by 36 · cited 1×
“Most of the treatments used in osteoporosis fall into this group: bisphosphonates, selective oestrogen receptor modulators (SERMs), calcitonin and denosumab [95].”
BackgroundOsteoporosis screening and risk management.
Wilkins, C. H. (2007) · PubMed Central · Cited by 34
Effect of calcium glucoheptonate on proliferation and osteogenesis of osteoblast-like cells in vitro
Modi, P. K., Prabhu, A., Bhandary, Y. P., Sudheer Shenoy, P., Hegde, A., Sindhu Priya, E. S., Johnson, R. P., Das, S. P., Vazirally, S., & Rekha, P. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222240 · Cited by 34 · cited 7×
“Alkaline phosphatase (ALP) is an enzyme associated with the plasma membrane of cells produced by osteoblasts, which play an important role in osteoid formation and mineralization.”
BackgroundInfluentialSpatiotemporally controlled calcitonin delivery: Long-term and targeted therapy of skeletal diseases
Yu, P., Liu, Y., Xie, J., & Li, J. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.056 · Cited by 34 · cited 1×
“In the treatment of diseases mainly caused by osteoporosis, such as hypercalcemia, the use of hydrogels may present an advantage for the regulation of calcium formation [155].”
BackgroundUtilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
(2006) · Europe PMC (PubMed Central) · Cited by 33
van Geel, T. A. C. M., Eisman, J. A., Geusens, P., van den Bergh, J. P., & Dinant, G. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.10.021 · Cited by 30 · cited 1×
“Although some clinical calculators, such as FRAX, are recommended by several guidelines for screening decisions, fracture risk calculation is still underestimated [114].”
BackgroundBehfarnia, P., Saied‐Moallemi, Z., Javanmard, S. H., & Naseri, R. (2016) · Advanced Biomedical Research · doi:10.4103/2277-9175.180992 · Cited by 30 · cited 1×
“Chronic cigarette smoking suppresses the production of OPG, a protein that works as an inhibitor of osteoclastogenesis, which results in an increase in the number of osteoclasts, thus favoring bone resorption processes [220].”
BackgroundAlginate-hydrogel versus alginate-solid system. Efficacy in bone regeneration in osteoporosis
García‐García, P., Reyes, R., Pérez‐Herrero, E., Arnau, M. R., Évora, C., & Delgado, A. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111009 · Cited by 30 · cited 1×
“This study reflects the importance of modifying the physical properties of hydrogels to optimize regenerative therapies [153].”
BackgroundKarunanithi, R., Ganesan, S., Panicker, T. M., Mp, K., & Jagadeesan, K. (2007) · Journal of Medical Physics · doi:10.4103/0971-6203.37481 · Cited by 29
The burden and undertreatment of fragility fractures among senior women
Rodrigues, A. M., Eusébio, M., Santos, M. J., Gouveia, N., Tavares, V., Coelho, P. S., Mendes, J. M., Branco, J., & Canhão, H. M. (2018) · Archives of Osteoporosis · doi:10.1007/s11657-018-0430-z · Cited by 29
Rates of bone loss in young adult males
SPECKER, B. L., Wey, H. E., & Smith, E. P. (2010) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.10.7 · Cited by 28 · cited 1×
“Environmental factors include: (a) nutritional factors, such as deficient calcium intake, vitamin D deficiency due to nutritional problems, poor absorption or low sun exposure, excessive protein intake in unbalanced diets, excessive phosphate intake or excessive salt intake that increases urinary calcium loss [22]; (b…”
BackgroundIbandronate: Pharmacology and preclinical studies
Russell, R. G. G. (2006) · Bone · doi:10.1016/j.bone.2006.01.151 · Cited by 28
Seeman, E. (2001) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740170043 · Cited by 28
Kamimura, M., Nakamura, Y., Sugino, N., Uchiyama, S., Komatsu, M., Ikegami, S., Kato, H., & Taguchi, A. (2016) · Scientific Reports · doi:10.1038/srep29199 · Cited by 27 · cited 1×
“(iii) A loss of height, as vertebral fractures and hyperkyphosis can result in a decrease in height of about 10–20 cm, approximately [21].”
Background
Research works printed but not linked: 2
- Quevedo, 2008, [Vitamin D receptor gene polymorphisms and risk of hip fracture in Chilean elderly women], Rev. Med. Chile, 136, 475
- Società Italiana Dell’osteoporosi del Metabolismo Minerale e delle Malattie dello Scheletro (2004). Clinical Cases in Mineral and Bone Metabolism: The Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases, CIC Edizioni Internazionali.
Cited by
Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics
Adejuyigbe, B., Kallini, J., Chiou, D., & Kallini, J. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914583 · Cited by 148
“Local molecules such as TGF-β play a pivotal role in attracting and preparing osteoblasts to initiate bone formation [4,6,7].”
InfluentialHsu, S.-H., Chen, L.-R., & Chen, K.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212139 · Cited by 117
“Although this condition affects both men and women, it predominantly occurs in women aged 51 to 75, who are characterized by accelerated bone loss during this period [14].”
Cellular senescence in skeletal disease: mechanisms and treatment
He, X., Hu, W., Zhang, Y., Chen, M., Ding, Y., Yang, H., He, F., Gu, Q., & Shi, Q. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00501-5 · Cited by 107
“Unfortunately, although various drugs, (such as bisphosphonates, recombinant human parathyroid hormone, denosumab for OP, and paracetamol for OA), have been licenced, their benefits are limited due to side effects or the poor overall health of elderly individuals (2, 3).”
BackgroundThe emerging role of Piezo1 in the musculoskeletal system and disease
Lei, L., Wen, Z., Cao, M., Zhang, H., Ling, S. K.-K., Fu, S., Qin, L., Xu, J., & Yung, P. S. (2024) · Theranostics · doi:10.7150/thno.96959 · Cited by 83
“In clinical scenarios, appropriate physical activity is beneficial for patients with musculoskeletal disorders, including OP [161], OA [162], muscle atrophy [163], IDD [164], and tendinopathy [165].”
BackgroundFeng, R., Wang, Q. K., Yu, T., Hu, H., Wu, G., Duan, X., Jiang, R., Xu, Y., & Huang, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112341 · Cited by 73
Metadata
- Authors
- Aibar-Almazán, A., Voltes-Martínez, A., Castellote-Caballero, Y., Afanador-Restrepo, D. F., Carcelén-Fraile, M. D. C., & López-Ruiz, E.
- Affiliations
- Department of Health Sciences, Campus de Las Lagunillas SN, University of Jaén, E-23071 Jaén, Spain
- Universidad de Granada (ES)
- Fundación Universitaria del Área Andina (CO)
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-08-21
- Volume
- 23
- Issue
- 16
- Pages
- 9465
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9408932
- OpenAlex
- W4293030541
- Cited by
- 412
- References
- 229
- Citations by year
- 2026: 79 · 2025: 156 · 2024: 128 · 2023: 43 · 2022: 6
- FWCI
- 18.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- 2014–2020 Operational Programme FEDER in Andalusia (FMM-AP17196-2019)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- osteoporosis, osteoporosis diagnosis, bone densitometry, dual-energy X-ray absorptiometry, anti-resorptive drugs, regenerative medicine, cell therapy, bioactive hydrogels, non-pharmacological treatment, physical activity, diet, smoking, alcohol consumption, bone resorption, bone biology, postmenopausal women, older adults
- MeSH terms
- Aged, Bone Resorption, Female, Humans, Osteoporosis, Smoking, Health Behavior, Exercise, Bone Density, Osteoporosis, Postmenopausal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.